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Cutaneous plasmacytosis is a rare entity that has been reported almost exclusively in Asian countries and is usually seen in adult
males. Primary cutaneous plasmacytosis clinically is characterized by multiple red-brown plaques and nodules typically located on
the trunk. We report a case of a Moroccan 65-year-old man presented multiple inﬁltrated red plaques on the extremities and the trunk,
the diagnosis of cutaneous plasmacytosis was retained without systemic involvement. To our knowledge, this is the ﬁrst case of this type
reported in a Moroccan adult man.
 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Cutaneous plasmacytosis is a rare skin disorder of
unknown etiology. This condition has been recognized
principally in Asian patients, with a few cases in whites
(Xia et al., 2013). Patients presented clinically with multi-
ple, red-brown inﬁltrated plaques and ﬂat tumors, mainly
located on the trunk. The condition can be systemic if poly-
clonal hypergammaglobulinemia, lymphadenopathy, cuta-
neous lesions, and systemic symptoms such as fever,
weight loss, and fatigue are present (Cheng et al., 2012).
We report a case of 65-year-old man born and grew up
in Rabat, presented a primary cutaneous plasmacytosis. Tohttp://dx.doi.org/10.1016/j.jssdds.2013.11.003
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a Moroccan adult man.2. Case report
A 65-year-old male presented with a 2-year history of
skin lesions that initially appeared on his lower limbs, then
gradually thereafter on his trunk and upper limbs. The
lesions were not pruritic. The patient was otherwise healthy
and denied any systemic symptoms. His family history was
unremarkable for skin disorders or lymphoproliferative
disease. On physical examination, the patient had multiple
1 to 6 cm red-brownish macules and inﬁltrated plaques dis-
seminated symmetrically on the trunk, abdomen, back,
upper and lower extremities, sparing the face, scalp and
palmoplantar regions (Figs. 1–4) with edema of the lower
limbs. There was no enlargement of lymph nodes, liver or
spleen.
A skin biopsy taken from his lower limbs showed the
presence of a dermal nodular and perivascular mixed cell
inﬁltrate with predominance of plasma cells without atyp-Saud University.
ommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. Diﬀuse reddish-brown inﬁltrated plaques on the chest.
Fig. 2. Diﬀuse reddish-brown inﬁltrated plaques on the abdomen.
Fig. 3. Diﬀuse reddish-brown inﬁltrated plaques on the buttocks.
Fig. 4. Diﬀuse reddish-brown inﬁltrated plaques on the upper limbs and
lower limbs.
Fig. 5. Presence of dermal mixed cell inﬁltrate with predominance of
plasma cells with perivascular and periadnexal inﬁltrates of plasma cells.
Hematoxylin-eosin stain, original magniﬁcation:  40.
Fig. 6. Monoclonal expression of Kappa light chain by plasma cells.
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Immunohistochemical study revealed polyclonality of
plasma cells with expression of kappa and lambda light
chain (Figs. 6 and 7 and 8).
Laboratory test results revealed no abnormalities in the
hemogram. Tests for syphilis and HIV infection were neg-
ative. Serologic tests for hepatitis virus types B and C were
negative. Serum protein electrophoresis detected poly-
clonal hypergammaglobulinemia with Ig G 35 g/l (normal,
7–16 g/l), Ig A 6.5 g/l (normal 0.7–4 g/l) and Ig M 3.78 g/l
(normal 0.4–2.3). The urine electrophoresis study did not
show Bence-Jones protein. A chest radiography and com-
puted tomography scan revealed no apparent extracutane-
ous involvement.Following the diagnosis of primary cutaneous plasma-
cytosis, oral corticosteroids were given with prednisone
40 mg/day which seemed to stabilize the lesions.3. Discussion
Cutaneous and systemic plasmacytosis is a rare reactive
lymphoplasmacytic disorder. It was ﬁrst described in the
Fig. 7. Negative Lambda signal.
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cytosis and further characterized by Kitamura in 1980
(Honda et al., 2013; Leonard et al., 2007). Since that, it
was described in Asian patients and particular in Japanese
individuals (Shadel et al., 2010).
Cutaneous plasmacytosis is characterized by cutaneous
lesions composed of mature polyclonal plasma cell inﬁl-
trates and polyclonal hypergammaglobulinemia (Uhara
et al., 1994). The condition has been subsequently named
cutaneous and systemic plasmacytosis when it is accompa-
nied by anemia, fever, lymphadenopathy and, rarely, inter-
stitial pneumonia (Shimizu et al., 1997).
Primary cutaneous plasmacytosis manifests as dissemi-
nated red brown cutaneous nodules or plaques mainly on
the trunk, face or extremities (Ma et al., 2008). In our
patient, the red indurated plaques on the extremities with
edema of the lower limbs recalled the classic Kaposi’s
disease.
Histopathologically, lesions of cutaneous plasmacytosis
are characterized by a dense perivascular inﬁltrates of
mature plasma cells in the dermis without atypical features.
The immunohistochemistry demonstrated the polyclonality
of inﬁltrating plasma cells (Amin et al., 2002).
The etiology of cutaneous plasmacytosis is unknown,
multiple theories have been proposed. The geographic dis-
tribution of cases has caused speculation that a primary
infectious cause is responsible. The current evidence sug-
gests that a degranulated production of interleukine 6 plays
an important role in its pathogenisis (Kodama et al., 1992;
Yamamoto et al., 1997).
Although the majority of patients with cutaneous plas-
macytosis run a chronic benign course (Haque et al.,
2011), a few cases have demonstrated an aggressive clinical
course with a fatal outcome. There are reports of patients
with plasmacytosis developing malignant lymphomas
(Kanbe et al., 1998; Nitta, 1997).
It is essential to evaluate the patient for systemic disease
and the development of a more aggressive disorder and the
possibility of malignant transformation.Available treatments for cutaneous plasmacytosis
include topical and systemic corticosteroids, topical tacrol-
imus, systemic chemotherapy, topical photodynamic ther-
apy, PUVA and radiotherapy with poor clinical
responses (Miura et al., 2003; Tzung et al., 2005). In our
patient, cutaneous lesions were stable after treatment with
oral corticosteroids.
4. Conclusion
The dermatologist and dermatopathologist must be
aware of this entity and its associations. It is essential to
evaluate the patient for systemic disease and the develop-
ment of a more aggressive disorder.
Description of new cases of cutaneous and systemic
plasmacytosis in our country should prompt a search for
infectious or environmental cause of the disease.Conﬂict of interest
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